Patient Leaflet Updated 27-Aug-2024 | Tillomed Laboratories Ltd
Esomeprazole 40 mg powder for solution for injection/infusion
Esomeprazole 40 mg powder for solution for injection/infusion
esomeprazole
1. What Esomeprazole is and what it is used for
2. What you need to know before Esomeprazole is given to you
3. How Esomeprazole is given to you
4. Possible side effects
5. How to store Esomeprazole
6. Contents of the pack and other information
Esomeprazole contains a medicine called esomeprazole. This belongs to a group of medicines called “proton pump inhibitors”. These work by reducing the amount of acid your stomach produces.
Esomeprazole is used for the short-term treatment of certain conditions, when you are unable to have treatment orally. It is used to treat the following conditions:
You must not be given Esomeprazole if any of the above apply to you. If you are not sure, talk to your doctor or nurse before you are given this medicine.
Talk to your doctor or nurse before you are given Esomeprazole if:
Esomeprazole may hide the symptoms of other diseases. Therefore talk to your doctor immediately, if any of the following applies to you before or after you are given Esomeprazole:
Using a proton pump inhibitor like esomeprazole may slightly increase your risk of fractures in the hip, wrist or spine, especially if used over a period of more than one year. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).
If you get a rash on your skin, especially in areas exposed to the sun, tell your doctor as soon as you can, as you may need to stop your treatment with esomeprazole. Remember to also mention any other ill-effects like pain in your joints.
Severe skin rashes have occurred in patients taking esomeprazole (see also section 4). The rash may cause ulcers in the mouth, throat, nose, genitals, and include conjunctivitis (red and swollen eyes). These severe skin rashes often appear after flu-like symptoms such as fever, head and limb pain. The rash may affect large parts of the body and are accompanied by blistering and peeling of the skin.
If at any time during treatment (even after several weeks) you develop a skin rash or any of these skin symptoms, stop taking this medicine and contact your doctor immediately.
This medicine may affect the way that your body absorbs vitamin B12, particularly if you need to take it for a long time. Please contact your doctor if you notice any of the following symptoms, which could indicate low levels of Vitamin B12:
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription. This is because esomeprazole can affect the way some medicines work and some medicines can have an effect on esomeprazole.
You must not be given esomeprazole if you are taking a medicine containing nelfinavir (used to treat HIV infection).
Tell your doctor or nurse if you are taking any of the following medicines:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before you are given this medicine.
Pregnancy
Your doctor will decide whether you can use esomeprazole during this time.
Breast-feeding
It is not known whether esomeprazole passes into breast milk. Therefore, you should not be given esomeprazole if you are breastfeeding.
Esomeprazole is not likely to affect you being able to drive or use machines. However, side effects such as dizziness and blurred vision may uncommonly occur (see section 4). If affected, you should not drive or use machines.
Each vial contains less than 1 mmol sodium (23 mg), that is to say essentially ‘sodium-free’.
Esomeprazole can be given to children and adolescents aged 1-18 years and adults, including the elderly.
Adults
Children and adolescents aged 1 to 18 years
If you think you have been given too much Esomeprazole, talk to your doctor immediately.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following serious side effects, stop taking Esomeprazole and contact a doctor immediately:
Other side effects include:
Common: (may affect up to 1 in 10 people)
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Very rare: (may affect up to 1 in 10,000 people)
Not known: frequency cannot be estimated from the available data
Esomeprazole, may, in very rare cases, affect the white blood cells and lead to immune deficiency. If you have an infection with symptoms such as fever and a severely reduced general condition of health, or fever with symptoms of a local infection such as pain in the neck, throat or mouth, or difficulties in urinating, you must see your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important that you give information about your medication at this time.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
The doctor or hospital pharmacist are responsible for storing, using and disposing of Esomeprazole correctly.
Do not use this medicine after the expiry date, which is stated on the carton and vial after ‘Exp’. The expiry date refers to the last day of that month.
Do not store above 25 °C.
Store in the original package, in order to protect from light. Vials can however be stored exposed to normal indoor light outside the box for up to 24 hours.
Do not refrigerate.
Chemical and physical in-use stability has been demonstrated for 12 hours at 30 °C.
From a microbiological point of view, unless the method of reconstitution precludes the risk of microbial contamination, the product should be used immediately.
If not used immediately, in-use storage times and conditions are the responsibility of user.
Do not use if solution shows signs of deterioration.
The active substance is esomeprazole sodium. Each vial of powder for solution for injection/infusion contains 42.5 mg of esomeprazole sodium, equivalent to 40 mg of esomeprazole.
The other ingredients are: disodium edetate and sodium hydroxide (for pH-adjustment).
Esomeprazole 40 mg powder for solution for injection/infusion is white to off white porous cake or powder. This is made into a solution before it is given to you.
Esomeprazole is filled in 5 ml type-I, clear glass vial stoppered with dark grey bromobutyl rubber stopper and sealed with purple aluminium flip off seal.
Esomeprazole is available in packs of 1, 10 and 50 vials.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer1
This leaflet was last revised in 12/2023
1 Only actual manufacturer stated on printed leaflet.
220 Butterfield, Great Marlings, Luton, LU2 8DL, UK
+44 (0)1480 402 402
+44 (0)1480 402 402
+44 (0)1480 402431 / +44 (0)1480 402432
http://www.tillomed.com/
+44 (0)1480 402 400
+44 (0)1480 402 400
+44 (0)1480 402431 / +44 (0)1480 402432